|
2019
|
Invention
|
Memantine combinations and use.
A pharmaceutical combination of memantine and a non-anticholiner... |
|
|
Invention
|
Method and composition for treating alzheimer-type dementia.
There is described a method for inc... |
|
|
Invention
|
Anticholinergic neuroprotective composition and methods.
The present invention relates to a phar... |
|
|
Invention
|
Muscarinic combinations and their use for combating hypocholinergic disorders of the central nerv... |
|
2018
|
Invention
|
Oxybutynin-xanomeline transdermal therapeutic system combinations.
Transdermal therapeutic syste... |
|
|
Invention
|
Use and composition for treating dementia.
There is described a method for increasing the maxima... |
|
2017
|
Invention
|
Memantine combinations and use. A pharmaceutical combination of memantine and a non-anticholinerg... |
|
|
Invention
|
Muscarinic m2-antagonist combination. A combination of a M2-receptor antagonist and a non-anticho... |
|
|
Invention
|
Method and composition for treating alzheimer-type dementia. 3 receptor antagonist, a dopamine an... |
|
|
Invention
|
Muscarinic m2-antagonist combinations. A combination of a M2-receptor antagonist, a non-anticholi... |
|
2016
|
Invention
|
Anticholinergic neuroprotective composition and methods. The present invention relates to a pharm... |
|
|
Invention
|
Muscarinic combination and its use for combating hypocholinergic disorders of the central nervous... |
|
|
Invention
|
Muscarinic combination of a selective m2-antagonist and a peripheral non-selective antagonist for... |
|
|
Invention
|
Oxybutynin-xanomeline transdermal therapeutic system combinations. Transdermal therapeutic system... |
|
|
Invention
|
Oxybutynin transdermal therapeutic system muscarinic agonist combination. Pharmaceutical composit... |
|
|
Invention
|
Peripheral-anticholinergic muscarinic agonist combination.
A combination of a non-selective, per... |
|
|
Invention
|
Peripheral-anticholinergic muscarinic agonist combination. A combination of a non-selective, peri... |
|
|
Invention
|
Oxybutynin transdermal therapeutic system combination. There is described a pharmaceutical combin... |
|
2014
|
Invention
|
Use and composition for treating dementia. There is described a method for increasing the maximal... |
|
2013
|
Invention
|
Piperidinium quaternary salts. There are described new 1-alkyl-1-methyl-4-[(2,2-diphenyl-2-propox... |
|
2010
|
Invention
|
Method and composition for treating alzheimer-type dementia. There is described a method for incr... |
